Cargando…
Her2(Ile)655(Val) polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies
Breast cancer (BC) is one of the most common types of cancer in women worldwide. Several factors including genetic and environmental have been linked with susceptibility to development of BC. Her2 is a transmembrane protein with tyrosine kinase activity, overexpressed in several cancers including BC...
Autores principales: | Krishna, B. Madhu, Chaudhary, Sanjib, Panda, Aditya K., Mishra, Dipti Ranjan, Mishra, Sandip K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943262/ https://www.ncbi.nlm.nih.gov/pubmed/29743533 http://dx.doi.org/10.1038/s41598-018-25769-y |
Ejemplares similares
-
HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer
por: Mojtahedi, Zahra, et al.
Publicado: (2013) -
Association of +331G/A PgR Polymorphism with Susceptibility to Female Reproductive Cancer: Evidence from a Meta-Analysis
por: Chaudhary, Sanjib, et al.
Publicado: (2013) -
A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer
por: Nelson, Stephanie E, et al.
Publicado: (2005) -
Influence of Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in early-stage HER2 positive breast cancer
por: Vazdar, Ljubica, et al.
Publicado: (2021) -
HER2(Ile655Val) Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis
por: Thanh, Tung Nguyen, et al.
Publicado: (2021)